Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The risk-benefit ratio of left atrial appendage closure (LAAC) versus systemic therapy (warfarin) for prevention of stroke, systemic embolism, and cardiovascular death in nonvalvular atrial fibrillation (NVAF) requires continued evaluation.

          Related collections

          Author and article information

          Journal
          J. Am. Coll. Cardiol.
          Journal of the American College of Cardiology
          1558-3597
          0735-1097
          Jun 23 2015
          : 65
          : 24
          Affiliations
          [1 ] Mayo Clinic, Rochester, Minnesota. Electronic address: holmes.david@mayo.edu.
          [2 ] St. John's Health Center, Santa Monica, California.
          [3 ] Cedars Sinai Medical Center, Los Angeles, California.
          [4 ] Scripps Clinic, La Jolla, California.
          [5 ] Mercy Hospital, St. Louis, Missouri.
          [6 ] Cardiovascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany.
          [7 ] Methodist Hospital, Houston, Texas.
          [8 ] Mount Sinai School of Medicine, New York, New York.
          Article
          S0735-1097(15)02023-9
          10.1016/j.jacc.2015.04.025
          26088300
          Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

          Comments

          Comment on this article